Document is current
Any future updates will be listed below
-
Authors
Chauvin, Samuel D.
Price, Susan
Zou, Juan
Hunsberger, Sally
Brofferio, Alessandra
Matthews, Helen
Similuk, Morgan
Rosenzweig, Sergio D.
Su, Helen C.
Cohen, Jeffrey I.
Lenardo, Michael J.
Ravell, Juan C.
-
Funding
Funding for this research was provided by:
national institute of allergy and infectious diseases
office of extramural research, national institutes of health (T32 GM007170)
-
License Information
Text and Data Mining valid from 2021-10-16
Version of Record valid from 2021-10-16
-
More Information
Article History
Received: 27 July 2021
Accepted: 7 September 2021
First Online: 16 October 2021
Declarations
:
: This study followed the principles of the Declaration of Helsinki, the International Conference on Harmonization (ICH)-Good Clinical Practice (GCP) guidelines, and the National Institute of Allergy and Infectious Diseases (NIAID) guidelines. This trial is registered at the US National Institutes of Health (ClinicalTrials.gov) #NCT02496676.
: All patients or their legal representatives provided written informed consent.
: Not applicable.
: The authors declare no competing interests.
